Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Genetic Tech Spn Ads (GENE)

Genetic Tech Spn Ads (GENE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Genetic Technologies Interview to Air on Bloomberg International on the RedChip Money Report

Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, "Company"), a diversified molecular diagnostics company, announced today an interview with interim-CEO Dr. Jerzy Muchnicki will air on The RedChip...

GENE : 1.85 (-4.64%)
Genetic Technologies Provides Shareholder Update on Recent Achievements and Upcoming Milestones

Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, "Company"), a diversified molecular diagnostics company, announced today an update to shareholders on recent achievements and upcoming milestones.

GENE : 1.85 (-4.64%)
Genetic Technologies Limited (ASX Code: GTG; NASDAQ Ticker: GENE) announces successful completion of two new ground-breaking Genetic Risk Tests - for Colorectal Cancer and for Breast Cancer

Genetic Technologies Limited (ASX: GTG; NASDAQ Ticker: GENE) is delighted to announce that following substantial scientific research and genetic product development, two new ground-breaking cancer risk...

GENE : 1.85 (-4.64%)
Genetic Technologies Receives Nasdaq Notification Letter

Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) announces that it has received a letter from the Nasdaq Stock Market April 29, 2019, advising that the Company's reported...

GENE : 1.85 (-4.64%)
Genetic Technologies and The Translational Genomics Research Institute of Phoenix, Arizona Sign Memorandum of Understanding

Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE) ("Company"), a provider of world-leading genetic risk assessment test products, is pleased to announce that it has now established a Memorandum of...

GENE : 1.85 (-4.64%)
Genetic Technologies Asian Operations Established in Hainan, China

Highlights

GENE : 1.85 (-4.64%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI -1.44 , AIZ -0.17 , SBAC -3.04 , SO -0.10 , WELL -1.34
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar